What Is A Master Collaboration Agreement
A cooperation agreement (cooperation agreement) is also called a cooperation agreement and is an agreement between two (2) or more organizations (or individuals) who wish to cooperate to pursue a defined or limited trade goal. Essentially, a cooperation agreement is a kind of joint venture without its own legal personality, since employees must bring resources and decide on the ownership of the product. In the technology sector, the main legal issues relate to the contribution and licensing of intellectual property (IPIs), ownership of the property during the investigation period and the rules in force at the end of the validity period. Considering The purpose of this master collaboration agreement (“agreement”) is to create a master contract between TGen and GTG, under which TGen and GTG approve certain projects listed in the exhibits. . Negotiate the value of your contribution to a joint venture. This licensing agreement (this “agreement”) is entered into from [ ] 20 [ (“Execution Date”) from and between Gilead Sciences, Inc., a company that is organized and exists under Delaware state law and has its main location on 333 Lakeside Drive, Foster City, California 94404 (“Gilead”), and [Scholar Rock], [a Delaware State evidence with a headquarters on 620 Memorial Drive] 2nd Floor, Cambridge, Massachusetts 02139] (SR). Gilead and SR are referred to by name or “party” or, together, as “parties.” This amendment No. 2 to the amended and revised Master Collaboration Agreement (this “Amendment 2”) is adopted on September 28, 2017 (“Amendment No.) 2 Effective Date”), between bluebird bio, Inc. (“Bluebird”), a Delaware Corporation, and Celgene Corporation, a Delaware Corporation (Celgene Corp.), and Celgene European Investment Company LLC (“Celgene Europe”), a Delaware limited liability company (Celgene Europe and Celgene Corp.). “Celgene”).
Anyone from Bluebird and Celgene can be called a “party” or “parts” together. It refers to this modified and revised Master Collaboration Agreement of 3 June 2015 as amended (the “agreement”) by and between Bluebird, Celgene Corp. and Celgene Europe. The wholesale terms that are used here, but which are not defined differently, have the meaning given to those terms in the agreement.